Of vaccines and adjuvants: the warriors that protect us from infections
DOI:
https://doi.org/10.30973/inventio/2023.19.49/4Keywords:
Vaccines, Adjuvants, Preventive MedicineAbstract
Vaccines are undoubtedly one of the most valuable tools in the history of medicine, as they have made it possible to prevent numerous viral and bacterial infections, both for humans and for animal species. According to the WHO, vaccines currently prevent 2-3 million deaths every year in the human population. in this article we present a brief overview of the history of vaccines, as well as details of their formulation in terms of the molecules with which they are generally developed, termed as immunogens and adjuvants due to their functional nature. Immunogens are the parts of the vaccine that trigger a specific immune response against the infectious agent the vaccine is targeted against. Adjuvants, on the other hand, enhance the resulting immune response. This article presents, in a simple and accessible way, the complexity behind the working of vaccines and the immunological mechanisms they give rise to, in order to provide an adequate protection.
References
Abbas, A. K., Lichtman, A. H. y Pillai, S. (2022). Cellular and molecular immunology. Elsevier. https://shop.elsevier.com/books/cellular-and-molecular-immunology/abbas/978-0-323-75748-5
Clem, A. S. (2011). Fundamentals of vaccine immunology. Journal of Global Infectious Disease, 3(1), 73-8. https://doi.org/10.4103/0974-777X.77299
Christensen, D. (2016). Vaccine adjuvants: Why and how. Human Vaccines & Immunotherapeutics, 12(10), 2709-2711. https://doi.org/10.1080/21645515.2016.1219003
De Gregorio, E., Caproni, E., Ulmer, J. B. (2013). Vaccine adjuvants: mode of action. Frontiers in Immunology, 4, 214. https://doi.org/10.3389/fimmu.2013.00214
Desmond, A. y Offit, P. A. (2021). On the shoulders of giants—from Jenner’s cowpox to mRNA COVID vaccines. New England Journal of Medicine, 384(12), 1081-1083. https://doi.org/10.1056/NEJMp2034334
Facciolà, A., Visalli, G., Laganà, A. y Di Pietro, A. (2022). An overview of vaccine adjuvants: current evidence and future perspectives. Vaccines, 10(5), 819. https://doi.org/10.3390/vaccines10050819
Groce, N. E., Banks, L. M. y Stein, M. A. (2021). The global polio eradication initiative-polio eradication cannot be the only goal. Lancet Glob Health, 9(9), e1211. http://doi.org/10.1016/S2214-109X(21)00314-4
Jensen, F. C., Savary, J. R., Diveley, J. P. y Chang, J. C. (1998). Adjuvant activity of incomplete Freund’s adjuvant. Adv Drug Deliv Rev, 32(3), 173-186. https://doi.org/10.1016/s0169-409x(98)00009-x
Kang, S. M. y Compans, R. W. (2009). Host responses from innate to adaptive immunity after vaccination: molecular and cellular events. Molecules and Cells, 27(1), 5-14. https://doi.org/10.1007/s10059-009-0015-1
Kayser, V. y Ramzan, I. (2021). Vaccines and vaccination: history and emerging issues. Human Vaccines Immunotherapeutics, 17(12), 5255-5268. https://doi.org/10.1080/21645515.2021.1977057
Kirby, T. (2020). WHO celebrates 40 years since eradication of smallpox. The Lancet Infectious Diseases, 20(2), 174. https://doi.org/10.1016/S1473-3099(20)30012-8
Laddu, D. R., Biggs, E., Kaar J., Khadanga S., Alman, R. y Arena R. (2023). The impact of the COVID-19 pandemic on cardiovascular health behaviors and risk factors: a new troubling normal that may be here to stay. Progress in Cardiovascular Diseases, 76, 38-43. http://doi.org/10.1016/j.pcad.2022.11.017
Lowe, D. (2023). Enhancing the Enhancers in Vaccines. Science. https://www.science.org/content/blog-post/enhancing-enhancers-vaccines
Mahmood, F., Xu, R., Awan, M. U. N., Song, Y., Han, Q., Xia, X., Wei, J., Xu, J., Peng, J. y Zhang, J. (2023). HBV vaccines: advances and development. Vaccines, 11(12), 1862. https://doi.org/10.3390/vaccines11121862
Majid, U., Shahzaeem Hussain, S. A., Zahid, A., Hasnain Haider, M. y Arora, R. (2023). Mental health outcomes in health care providers during the COVID-19 pandemic: an umbrella review. Health Promotion International, 38(2), 1-11. http://doi.org/10.1093/heapro/daad025
Mbani, C. J., Nekoua, M. P., Moukassa, D. y Hober, D. (2023). The fight against poliovirus is not over. Microorganisms, 11(5), 1323. https://doi.org/10.3390/microorganisms11051323
Mohseni Afshar, Z., Barary, M., Hosseinzadeh, R., Karim B., Ebrahimpour, S., Nazary, K., Sio, T. T., Sullman, M. J. M., Carson-Chahhoud, K., Moudi, E. y Babazadeh, A. (2022). COVID-19 vaccination challenges: a mini-review. Human Vaccines & Immunotherapeutics, 18(5), 2066425-1-9. http://doi.org/10.1080/21645515.2022.2066425
Naseer, S., Khalid, S., Parveen, S., Abbass, K., Song, H. y Achim, M. V. (2023). COVID-19 outbreak: Impact on global economy. Front Public Health, 10, 1-13. https://doi.org/10.3389/fpubh.2022.1009393
Orenstein, W. A., Offit, P. A., Edwards, K. M. y Plotkin, A. (2022). Plotkin’s vaccines, Elsevier. https://www.sciencedirect.com/book/9780323357616/plotkins-vaccines
Organización Mundial de la Salud (1976). Immunological adjuvants: report of a WHO scientific group [meeting held in Geneva from 6 to October 1975]. Technical Report Series No. 595. OMS. https://iris.who.int/handle/10665/41209
Plotkin, S. (2014). History of vaccination. Proceedings of the National Academy Sciences, 111(34), 12283-12287. https://doi.org/10.1073/pnas.1400472111
Pulendran, B. y Ahmed, R. (2011). Immunological mechanisms of vaccination. Nature Immunology, 12(6), 509-517. http://doi.org/10.1038/ni.2039
Qin, F., Xia, F., Chen, H., Cui, B., Feng, Y., Zhang, P., Chen, J. y Luo, M. (2021). A guide to nucleic acid vaccines in the prevention and treatment of infectious diseases and cancers: from basic principles to current applications. Frontiers in Cell and Developmental Biology, 9, 633776. https://doi.org/10.3389/fcell.2021.633776
Reed, S. G., Orr, M. T. y Fox, C. B. (2013). Key roles of adjuvants in modern vaccines. Nature Medicine, 19(12), 1597-608. https://doi.org/10.1038/nm.3409
Saleh, A., Qamar, S., Tekin, A., Singh, R. y Kashyap, R. (2021). Vaccine development throughout history. Cureus, 13(7), e16635. https://doi.org/10.7759/cureus.16635
Silverstein, A. y Genevieve, M. (2009 [1989]). The Royal Experiment of Immunity. En A. M. Silverstein, A History of Immunology (pp. 24-35). Elsevier. https://www.sciencedirect.com/book/9780123705860/a-history-of-immunology
Travieso, T., Li, J., Mahesh, S., Mello, J. D. F. R. E. y Blasi, M. (2022). The use of viral vectors in vaccine development. NPJ Vaccines, 7, 75. https://doi.org/10.1038/s41541-022-00503-y
Waldman, S. E., Adams, J. Y., Albertson, T. E., Juárez, M. M., Myers, S. L., Atreja, A., Batra, S., Foster, E. E., Huynh, C. V., Liu, A. Y., Lubarsky, D. A., Ngo, V. T., Sandrock, C. E., Taylor, S. L., Tompkins, A. M. y Cohen, S. H. (2021). Real-world impact of vaccination on coronavirus disease 2019 (COVID-19) incidence in healthcare personnel at an academic medical center. Infect Control Hosp Epidemiol, 43(9), 1194-1200. http://doi.org/10.1017/ice.2021.336
Zhao, T., Cai, Y., Jiang, Y., He, X., Wei, Y., Yu, Y. y Tian, X. (2023). Vaccine adjuvants: mechanisms and platforms. Signal Transduction and Targeted Therapy, 8, 283. https://doi.org/10.1038/s41392-023-01557-7
Downloads
Published
Issue
Section
License
Copyright (c) 2005 Gladis Fragoso, Gabriela Rosas-Salgado, Gabriela Meneses-Ruiz, Raúl J. Bobes, Edda Sciutto
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Esta revista proporciona acceso abierto inmediato a su contenido, con base en el principio de ofrecer al público un acceso libre a las investigaciones para contribuir a un mayor intercambio global de conocimientos. Se distribuye bajo una licencia Creative Commons Reconocimiento-NoComercial 4.0 Internacional License.
